Drug profile · INN
epinephrine bitartrate
FLAVALTA
epinephrine bitartrate (FLAVALTA) is a adrenergic receptor agonist. Route of administration: injection. Current US regulatory status: approved.
Drug details — epinephrine bitartrate
- US status
- approved
- Class
- —
- Route
- INJECTION
- Patents
- 0
- Programs
- 3
- Data quality
- 0.84
Quick answer
epinephrine bitartrate (FLAVALTA) is a adrenergic receptor agonist. Route of administration: injection. Current US regulatory status: approved.
Key facts
Mechanism of action
Adrenergic receptor agonist
Primary target: Adrenergic receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is epinephrine bitartrate?
epinephrine bitartrate (FLAVALTA) is a adrenergic receptor agonist. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for epinephrine bitartrate?
FLAVALTA is a marketed brand name for epinephrine bitartrate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of epinephrine bitartrate?
epinephrine bitartrate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.